TVRD EPS Estimates
Tvardi Therapeutics, Inc.
$1.06
+$0.06(+6.00%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$13.34M
Volume
20.52K
52W Range
$0.93 - $7.23
Target Price
$9.25
TVRD EPS estimates: the consensus estimate for Tvardi Therapeutics, Inc.'s current fiscal year is -$2.35 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TVRD EPS Estimates
- EPS estimate, current quarter
- $-0.51
- EPS estimate, next quarter
- $-0.55
- EPS estimate, current year
- $-2.35
- EPS estimate, next year
- $-2.78
- EPS growth, 3-year
- +19.81%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.46 |
| 2024 | $-46.59 |
| 2023 | $-6.57 |
| 2022 | $-4.77 |
| 2021 | $-5.22 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TVRD | $1.06 | +6.0% | 20.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tvardi Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW